Robotics funding in Q3 2026: 35 deals, $1.85bn disclosed, half-size rounds and a Chinese IPO wave
MEKAWIRE's verified records show 35 robotics capital events in July to September 2026, 19 of them with a disclosed amount totalling $1.846bn, flat with Q2's $1.790bn but on almost twice as many disclosed deals.
The median disclosed round fell to $40m from $155m in Q2, seven rounds of $100m or more took 83% of the dollars, and six of China's nine events were stock-market listings rather than private rounds.
Robotics money did not dry up in the third quarter of 2026. It broke into smaller pieces. MEKAWIRE's verified database logs 35 capital events between July 1 and September 30, and the 19 with a disclosed amount add up to $1.846bn, slightly above the $1.790bn disclosed in the second quarter. The median disclosed round, however, fell to $40m from $155m.
That combination, flat dollars and a collapsing median, is the story of the quarter. It says investors are writing more cheques to more companies, while the era of a few multi-billion-dollar rounds that defined the first quarter has paused. The question this piece answers is where the money went instead, and whether the shift is a pause or a new pattern.
The quarter in four numbers
First, deal count. The 35 events in Q3 compare with 23 in Q2 and 36 in Q1. Second, disclosed dollars: $1.846bn in Q3 against $1.790bn in Q2 and $7.792bn in Q1. Third, concentration: the seven rounds of $100m or more raised $1.527bn, or 82.7% of everything disclosed. Fourth, opacity: 16 of the 35 events, 46%, carry no dollar figure in our tables, mostly listings and Korean share placements whose proceeds we have not converted.
- Q1
- 36
- 23
- $7.792bn
- $120m
- Q2
- 23
- 10
- $1.790bn
- $155m
- Q3
- 35
- 19
- $1.846bn
- $40m
Median of disclosed amounts only. Q1 includes Saronic ($1.75bn), Shield AI ($1.5bn) and Skild AI ($1.4bn). IPO proceeds and won-denominated placements are not counted as dollar amounts.
As of Oct 16, 2026
The first quarter is the outlier, not the third. Saronic's $1.75bn Series D, Shield AI's $1.5bn Series G and Skild AI's $1.4bn Series C together raised $4.65bn, 2.5 times every disclosed dollar of Q3. Strip those three defence and robot-brain mega-rounds out and the year looks far steadier than the headline totals suggest.
Who got the big cheques
The largest Q3 round went to a chip maker, not a robot maker. D-Robotics, the Chinese supplier of robot computing platforms, raised $400m in a Series C on Sept 17. Walden Robotics came out of stealth on July 15 with a $300m seed round at a $1.10bn post-money valuation, led by Deviation Capital, so investors priced a company with no disclosed product at 3.7 times the cash it raised. General Intuition reported $220m in a Form D filing, LimX Dynamics took $200m before a planned listing, Britain's Humanoid raised $152m at $1.35bn, edge-AI chip maker SiMa.ai $150m at $1.45bn and Korea's Holiday Robotics $105m.
- D-Robotics
- CN
- Series C
- $400m
- n/d
- Sept 17
- Walden Robotics
- US
- Seed
- $300m
- $1.10bn
- Jul 15
- General Intuition
- US
- Form D offering
- $220m
- n/d
- Sept 29
- LimX Dynamics
- CN
- Pre-IPO
- $200m
- n/d
- Jul 14
- Humanoid
- GB
- Series A
- $152m
- $1.35bn
- Jul 21
- SiMa.ai
- US
- Series C
- $150m
- $1.45bn
- Sept 28
- Holiday Robotics
- KR
- Series A
- $105m
- n/d
- Jul 13
Disclosed figures from company releases and filings recorded in MEKAWIRE. Walden post-money / raise = 1.10 / 0.30 = 3.7x.
As of Oct 16, 2026
Two of the top six are chip companies. Read together with Intel's and Micron's robotics remarks this month, the pattern suggests investors increasingly treat on-robot compute as a separate investable layer, as they once did with lidar for self-driving cars.
China went public instead of private
The sharpest regional shift is in China. Of nine Chinese capital events in our Q3 records, six were stock-market listings: Rokae Robotics, Mech-Mind Robotics, Excelland Robotics, Direct Drive Tech and Camsense in Hong Kong, and Unitree Robotics on Shanghai's STAR Market. Only D-Robotics and LimX disclosed private amounts, and those two alone account for $600m, 32.5% of Q3 disclosed dollars. Because we have not stored IPO proceeds as round amounts, Chinese capital raised in the quarter is understated in every table here.
The US still leads on private money: 15 events and $937m disclosed, 50.8% of the quarter's total. Korea logged five events, but only Holiday's Series A has a dollar figure in our tables; Wonik Robotics' KRW 350bn convertible preferred placement, AIDIN Robotics' strategic investment, Twinny's pre-IPO placement and Clobot's rights offering are recorded in won or without an amount.
MEKAWIRE analysis: the money is spreading, not shrinking
Q3 2026 shows robotics capital moving from a few bets on robot brains to many bets on layers, chips, data and specialised robots, while China moves its winners to public markets.
The evidence is the median falling by three quarters while total dollars held steady, the presence of two chip makers among the six largest rounds, and a listing wave that turns Chinese private valuations into daily prices. The strongest counter-argument is coverage. Our database records verified rounds from primary sources, not every deal, and a handful of unrecorded large rounds could move the median. The Q1 total also rests on three defence-heavy deals that may simply recur later.
The bull case is that a broader base of $20m to $100m rounds, six in Q3, produces more companies able to reach revenue before the next mega-round cycle. The bear case is that falling round sizes reflect investors waiting for the October and November listings and results (Agility's SPAC vote on Nov 2, Unitree's first quarterly report as a listed company) before committing again. October so far shows seven rounds and $360.6m disclosed in 16 days; at that pace the month would end near $700m, slightly above Q3's monthly average of about $615m (1,846 / 3).
Three dated signals will test the thesis: whether any robotics round above $1bn closes before Dec 31; the redemption rate in Agility Robotics' SPAC vote on Nov 2; and whether Hong Kong's Chapter 18C pipeline adds more robot companies in November.
- 6 of 9 events were IPOs (HKEX, STAR Market)
- 5 events; Holiday Robotics $105m Series A the only USD-denominated amount
- Verified, non-demo rows in MEKAWIRE's funding_rounds table, as of Oct 16, 2026
- 23 events, $1.790bn disclosed; median $155m
- 35 capital events in Q3 2026; 19 disclosed amounts totalling $1.846bn
- 7 rounds of $100m+ took $1.527bn (82.7%)
- D-Robotics $400m Series C, Sept 17
- $40m
Why it matters
Round size, not total dollars, is the leading indicator for how much runway robotics start-ups will have in 2027. A median of $40m funds roughly two years of a hardware team of 60 to 100 people; a median of $155m funded pilots at customer scale. If Q4 stays near Q3's median, expect more companies to seek strategic investors (automakers, electronics groups, chip makers) rather than another venture round.
The Chinese listing wave matters for valuation everywhere: Unitree, Mech-Mind and the Hong Kong 18C companies now publish prices and results, which gives private investors comparables they did not have in Q1.
Rival analysis
In humanoids, Humanoid (GB, $1.35bn post) and LimX (CN, pre-IPO) raised in Q3 while US leaders Figure and Apptronik were quiet in our Q3 records after large Q1 and earlier rounds. In compute, D-Robotics and SiMa.ai together raised $550m, against NVIDIA's Jetson franchise and Intel's announced 2028 Razer Lake AX part. In Korea, Holiday's $105m Series A is the only round that competes on size with US and European humanoid rounds.
Valuation context
Only three Q3 rounds disclosed a post-money valuation: Walden $1.10bn on a seed (3.7x raise), Humanoid $1.35bn (8.9x raise) and SiMa.ai $1.45bn (9.7x raise). Ratios computed as post-money divided by round size. Compare Skild AI's $14bn post on a $1.4bn Q1 round (10x). Seed-stage unicorn pricing at Walden is the outlier and suggests founder pedigree is still priced heavily even as median cheques shrink.
Supply-chain implications
Two of the six largest rounds fund robot compute (D-Robotics, SiMa.ai), and China's listings include a lidar and sensor maker (Camsense), a direct-drive motor maker (Direct Drive Tech) and a 3D vision supplier (Mech-Mind). Capital is moving down the bill of materials, which should ease component constraints for humanoid makers in 2027 but also raises the share of the robot's value captured by suppliers.
Signals to watch
1) Any robotics round above $1bn before Dec 31, 2026. 2) Redemption rate at Agility Robotics' SPAC vote, Nov 2. 3) New robotics filings under HKEX Chapter 18C in November. 4) Unitree's first quarterly results as a STAR Market company. 5) Q4 median round size in MEKAWIRE's tables versus Q3's $40m.
Analyst view
Thesis: money is spreading across layers rather than shrinking. Confidence: medium. Our records are verified but not exhaustive, and IPO proceeds are excluded, so China is understated and the median is sensitive to a few missing rounds. What would change our view: two or more $1bn-plus robot-brain rounds in Q4, which would mean Q3 was a pause, not a pattern.
Questions you should be asking
For investors: are you pricing robot compute companies as chip companies or as robotics companies? For Chinese listed robot makers: how much of IPO proceeds goes to capacity versus R&D? For Korean start-ups: with only one USD-scale round in Q3, is a domestic listing now the default exit?